Diamines & Chemicals Ltd
Incorporated in 1976, Diamines and Chemicals Ltd is in the business of manufacturing and marketing of organic chemicals compounds[1]
- Market Cap ₹ 249 Cr.
- Current Price ₹ 248
- High / Low ₹ 458 / 208
- Stock P/E
- Book Value ₹ 163
- Dividend Yield 0.40 %
- ROCE -7.24 %
- ROE -6.75 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 2.06% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.35% over past five years.
- Company has a low return on equity of 2.39% over last 3 years.
- Working capital days have increased from 207 days to 303 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 36 | 35 | 39 | 47 | 69 | 63 | 66 | 110 | 104 | 71 | 38 | |
| 34 | 31 | 25 | 27 | 28 | 34 | 38 | 44 | 54 | 80 | 65 | 52 | |
| Operating Profit | 5 | 4 | 9 | 12 | 19 | 35 | 25 | 22 | 56 | 24 | 6 | -13 |
| OPM % | 13% | 13% | 27% | 30% | 40% | 51% | 40% | 33% | 51% | 23% | 9% | -35% |
| 0 | 0 | 0 | -1 | 1 | 2 | 3 | 2 | 3 | 3 | 4 | 5 | |
| Interest | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Profit before tax | -0 | 0 | 6 | 8 | 18 | 35 | 26 | 22 | 57 | 24 | 6 | -13 |
| Tax % | 431% | -212% | 16% | 14% | 26% | 32% | 19% | 24% | 26% | 26% | 29% | -11% |
| -2 | 0 | 5 | 7 | 13 | 24 | 21 | 17 | 42 | 18 | 4 | -11 | |
| EPS in Rs | -1.58 | 0.26 | 4.91 | 7.25 | 13.42 | 24.52 | 21.50 | 17.09 | 43.16 | 18.16 | 4.59 | -11.05 |
| Dividend Payout % | 0% | 0% | 31% | 34% | 37% | 33% | 23% | 18% | 7% | 14% | 22% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -9% |
| 3 Years: | -30% |
| TTM: | -46% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -346% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -3% |
| 3 Years: | -27% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 10% |
| 3 Years: | 2% |
| Last Year: | -7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 24 | 24 | 28 | 33 | 39 | 55 | 75 | 90 | 125 | 141 | 156 | 154 |
| 20 | 16 | 7 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 10 | 9 | 9 | 10 | 11 | 11 | 9 | 10 | 17 | 14 | 17 | 9 | |
| Total Liabilities | 64 | 58 | 54 | 53 | 62 | 76 | 95 | 111 | 151 | 165 | 182 | 180 |
| 29 | 27 | 25 | 24 | 24 | 20 | 22 | 38 | 27 | 50 | 49 | 51 | |
| CWIP | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 21 | 1 | 2 | 19 |
| Investments | 0 | 0 | 1 | 1 | 0 | 2 | 6 | 13 | 27 | 30 | 30 | 25 |
| 34 | 30 | 27 | 27 | 36 | 53 | 66 | 58 | 76 | 84 | 101 | 86 | |
| Total Assets | 64 | 58 | 54 | 53 | 62 | 76 | 95 | 111 | 151 | 165 | 182 | 180 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 7 | 9 | 10 | 12 | 26 | 15 | 27 | 16 | 20 | -6 | -12 | |
| -2 | -0 | 1 | -3 | -9 | -13 | -15 | -22 | -9 | -17 | 15 | -28 | |
| -3 | -7 | -10 | -7 | -5 | -9 | -4 | -5 | -6 | -3 | 10 | 18 | |
| Net Cash Flow | -0 | -0 | -0 | 0 | -1 | 4 | -3 | 0 | 2 | -0 | 19 | -22 |
| Free Cash Flow | 5 | 7 | -0 | 16 | 10 | 23 | 4 | 15 | 6 | 13 | -10 | -33 |
| CFO/OP | 98% | 164% | 105% | 102% | 83% | 105% | 87% | 152% | 55% | 109% | -79% | 82% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 76 | 87 | 75 | 59 | 66 | 55 | 55 | 76 | 59 | 70 | 52 |
| Inventory Days | 193 | 155 | 195 | 185 | 301 | 197 | 284 | 43 | 234 | 135 | 336 | 473 |
| Days Payable | 55 | 34 | 48 | 100 | 131 | 81 | 65 | 45 | 105 | 40 | 93 | 44 |
| Cash Conversion Cycle | 211 | 196 | 233 | 160 | 229 | 183 | 273 | 54 | 204 | 153 | 313 | 480 |
| Working Capital Days | 32 | 26 | 164 | 88 | 71 | 76 | 103 | 40 | 97 | 108 | 211 | 303 |
| ROCE % | 6% | 5% | 16% | 23% | 38% | 61% | 34% | 24% | 48% | 17% | 4% | -7% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Production Volume - Specialty Chemicals MT |
|
|||||||||||
| Sales Volume - Specialty Chemicals MT |
||||||||||||
| Electricity Consumption per Tonne of Production Units/MT |
||||||||||||
| Wind Power Installed Capacity MW |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - We submit herewith copies of Notice published in Newspapers regarding transfer of shares of the Company to the Investor Education and Protection Fund.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY 2025-26 filed; no non-compliances observed.
-
Announcement Under Regulation 30 - Notice To Shareholders In Respect Of Transfer Of Shares Of The Company To The Investor Education And Protection Fund (IEPF)
29 May - Notice sent to shareholders on 29 May 2026 for transfer of unclaimed dividend shares to IEPF by 31 Aug 2026.
-
Statement Of Deviation & Variation Under Reg 32
18 May - Filed March 2026 deviation report for ₹50.58 crore warrant issue; ₹12.51 crore utilized, 2,69,402 shares allotted.
-
Disclosure under Regulation 30A of LODR
18 May - Tanmay Godiawala and Rajendra Chhabra re-appointed; cost, internal and tax auditors appointed for FY 2026-27.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
DCL is an ISO 9001:2015, ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018, and DSIR-certified sole manufacturer of ethylene amines in India. It also manufactures Piperazine Anhydrous and Piperazine Solutions.